Definitive Healthcare Corp. (NASDAQ:DH) Shares Sold by Jane Street Group LLC

Jane Street Group LLC cut its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 67.2% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 114,827 shares of the company’s stock after selling 235,032 shares during the period. Jane Street Group LLC owned about 0.10% of Definitive Healthcare worth $513,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in DH. The Manufacturers Life Insurance Company grew its holdings in shares of Definitive Healthcare by 17.0% during the second quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company’s stock worth $125,000 after buying an additional 3,332 shares in the last quarter. Principal Financial Group Inc. grew its holdings in shares of Definitive Healthcare by 10.8% during the second quarter. Principal Financial Group Inc. now owns 39,856 shares of the company’s stock worth $218,000 after buying an additional 3,874 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Definitive Healthcare by 31.4% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company’s stock worth $116,000 after buying an additional 5,083 shares in the last quarter. Glenmede Trust Co. NA grew its holdings in shares of Definitive Healthcare by 41.1% during the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock worth $82,000 after buying an additional 5,362 shares in the last quarter. Finally, Point72 DIFC Ltd grew its holdings in shares of Definitive Healthcare by 759.9% during the third quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock worth $42,000 after buying an additional 8,215 shares in the last quarter. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Definitive Healthcare

In related news, insider William Moschella sold 45,000 shares of Definitive Healthcare stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total value of $211,500.00. Following the transaction, the insider now directly owns 433,830 shares in the company, valued at $2,039,001. This trade represents a 9.40 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 14.84% of the stock is currently owned by insiders.

Definitive Healthcare Stock Performance

Shares of DH opened at $4.36 on Monday. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. The firm has a market cap of $503.68 million, a PE ratio of -1.41, a price-to-earnings-growth ratio of 3.29 and a beta of 1.40. The company’s 50 day simple moving average is $4.37 and its 200-day simple moving average is $4.58. Definitive Healthcare Corp. has a 12-month low of $3.19 and a 12-month high of $10.62.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on DH. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a report on Friday, November 8th. BTIG Research assumed coverage on shares of Definitive Healthcare in a research report on Tuesday, September 17th. They issued a “buy” rating and a $7.00 target price on the stock. Finally, Stephens assumed coverage on shares of Definitive Healthcare in a research report on Friday, December 20th. They issued an “equal weight” rating and a $5.00 target price on the stock. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, Definitive Healthcare has an average rating of “Hold” and a consensus target price of $5.72.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.